Patient Disposition and Baseline Characteristics
As of the data cutoff date of September 20, 2020, 83 patients (gilteritinib arm, n = 64; SC arm, n = 19) in ADMIRAL had undergone HSCT (Demographic and baseline characteristics of the patients who underwent HSCT are shown in Detailed transplantation characteristics were available for 55 gilteritinib arm patients who underwent HSCT (Nearly all patients in the SC arm underwent HSCT during the first 6 months of treatment, whereas in the gilteritinib arm, HSCTs were performed over a 12-month period (